Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)

CNY 11.41

(-0.26%)

Revenue Summary of Jiangsu gdk Biotechnology Co., Ltd.

  • Jiangsu gdk Biotechnology Co., Ltd.'s latest annual revenue in 2023 was 134.59 Million CNY , down -56.05% from previous year.
  • Jiangsu gdk Biotechnology Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 35.61 Million CNY , up 2158.47% from previous quarter.
  • Jiangsu gdk Biotechnology Co., Ltd. reported a annual revenue of 318.48 Million CNY in annual revenue 2022, down -18.81% from previous year.
  • Jiangsu gdk Biotechnology Co., Ltd. reported a annual revenue of 392.27 Million CNY in annual revenue 2021, down -33.41% from previous year.
  • Jiangsu gdk Biotechnology Co., Ltd. reported a quarterly revenue of 4.36 Million CNY for 2024 Q1, down -77.16% from previous quarter.
  • Jiangsu gdk Biotechnology Co., Ltd. reported a quarterly revenue of 35.61 Million CNY for 2024 Q3, up 2158.47% from previous quarter.

Annual Revenue Chart of Jiangsu gdk Biotechnology Co., Ltd. (2023 - 2017)

Historical Annual Revenue of Jiangsu gdk Biotechnology Co., Ltd. (2023 - 2017)

Year Revenue Revenue Growth
2023 134.59 Million CNY -56.05%
2022 318.48 Million CNY -18.81%
2021 392.27 Million CNY -33.41%
2020 589.09 Million CNY 777.27%
2019 67.15 Million CNY 0.0%
2018 - CNY 0.0%
2017 - CNY 0.0%

Peer Revenue Comparison of Jiangsu gdk Biotechnology Co., Ltd.

Name Revenue Revenue Difference
Beijing Tiantan Biological Products Co., Ltd. 5.18 Billion CNY 97.402%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 2.22 Billion CNY 93.953%
Jinyu Bio-technology Co., Ltd. 1.59 Billion CNY 91.579%
Vcanbio Cell & Gene Engineering Corp., Ltd 1.58 Billion CNY 91.534%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 17.28 Billion CNY 99.221%
Zhejiang Ausun Pharmaceutical Co., Ltd. 816.76 Million CNY 83.521%
DaShenLin Pharmaceutical Group Co., Ltd. 24.43 Billion CNY 99.449%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 5.47 Billion CNY 97.543%
GuiZhou SanLi Pharmaceutical Co.,Ltd 1.61 Billion CNY 91.684%
Pulike Biological Engineering, Inc. 1.25 Billion CNY 89.256%
Beijing Konruns Pharmaceutical Co.,Ltd. 920.01 Million CNY 85.371%
Shanghai Hile Bio-Technology Co., Ltd. 240.72 Million CNY 44.089%
Qingdao Vland Biotech INC. 1.18 Billion CNY 88.68%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 784.34 Million CNY 82.84%
Aurisco Pharmaceutical Co.,Ltd. 1.26 Billion CNY 89.34%
Zhejiang East Asia Pharmaceutical Co., Ltd. 1.35 Billion CNY 90.078%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 1.9 Billion CNY 92.936%
Mabwell (Shanghai) Bioscience Co., Ltd. 127.68 Million CNY -5.408%
Beijing Hotgen Biotech Co., Ltd. 541.25 Million CNY 75.133%
Assure Tech (Hangzhou) Co., Ltd. 503.35 Million CNY 73.261%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 1.02 Billion CNY 86.886%
Cabio Biotech (Wuhan) Co., Ltd. 443.8 Million CNY 69.673%
Shanghai Shen Lian Biomedical Corporation 301.48 Million CNY 55.357%
Nanjing Vazyme Biotech Co., Ltd. 1.28 Billion CNY 89.514%
Shandong Kexing Bioproducts Co,.Ltd 1.25 Billion CNY 89.31%
Shanghai Junshi Biosciences Co., Ltd. 1.48 Billion CNY 90.923%
Shanghai Model Organisms Center, Inc. 366.54 Million CNY 63.281%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 385.41 Million CNY 65.079%
Xiamen Amoytop Biotech Co., Ltd. 2.1 Billion CNY 93.592%
Novogene Co., Ltd. 2 Billion CNY 93.278%
Shanghai ZJ Bio-Tech Co., Ltd. 268.13 Million CNY 49.805%
Chengdu Olymvax Biopharmaceuticals Inc. 496.11 Million CNY 72.871%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 1.01 Billion CNY 86.727%
Shanghai Haohai Biological Technology Co., Ltd. 2.63 Billion CNY 94.892%
Jiangsu Bioperfectus Technologies Co., Ltd. 403.17 Million CNY 66.617%
Jiangsu Aidea Pharmaceutical Co., Ltd. 411.32 Million CNY 67.279%
Chengdu Easton Biopharmaceuticals Co., Ltd. 1.11 Billion CNY 87.952%
Sinocelltech Group Limited 1.88 Billion CNY 92.869%
Wuhan Keqian Biology Co.,Ltd 1.06 Billion CNY 87.351%
Shanghai Allist Pharmaceuticals Co., Ltd. 1.99 Billion CNY 93.242%
Anhui Huaheng Biotechnology Co., Ltd. 1.93 Billion CNY 93.056%
Youcare Pharmaceutical Group Co., Ltd. 4.19 Billion CNY 96.793%
Beijing Kawin Technology Share-Holding Co., Ltd. 1.41 Billion CNY 90.468%
Hangzhou Biotest Biotech Co.,Ltd. 442.11 Million CNY 69.557%